![BeVigilant Orafusion System logo_color (1) Vigilant Biosciences® Logo](https://vigilantbiosciences.com/wp-content/uploads/BeVigilant-Orafusion-System-logo_color-1.png)
Be among the first to be notified when available.
The first and only real-time early cancer detection system.
Together, we can save lives!
![Check Mark Icon](https://vigilantbiosciences.com/wp-content/uploads/2-2.png)
easy to use
A simple, non-invasive saliva test eliminates the need for invasive procedures, offering ease and convenience.
![Check Mark Icon](https://vigilantbiosciences.com/wp-content/uploads/2-2.png)
real-time results
Delivering fast results in 15 minutes or less, streamlining next steps and treatment decisions.
![Check Mark Icon](https://vigilantbiosciences.com/wp-content/uploads/2-2.png)
highly accurate*
Using multiple biomarkers in conjunction with clinical risk factors provides an accurate risk assessment.
How the BeVigilant™ OraFusion™ System Works
BeVigilant™ OraFusion™ System is an easy-to-use, accurate*, semi-quantitative tool for frontline healthcare clinicians assessing potentially at-risk patients for oral cancer.
The BeVigilant™ Reader is an advanced immunochromatography reader which captures the test data and provides the results during the patient’s visit.
The BeVigilant™ OraFusion™ System has been granted FDA Breakthrough Device Designation. Coming soon!
Be the first to know. Sign up and stay informed.
*Clinical Data on File